Hospital Anti-Infectives Insight Series

 

 

 

Click here to listen to John Lebbos, M.D., vice president of infectious diseases at Decision Resources give a presentation on the Hospital Anti-Infectives Insight Series reports.

 

 

Analyzing Hospital Antibiotic Prescribing Patterns and Receptivity to Emerging Agents

For more information on Hospital Anti-Infectives Insight Series and to see a list of 2010 titles, please visit our sister company, Arlington Medical Resources, Inc. (AMR).

AMR and Decision Resources’ Hospital Anti-Infectives Insight Series analyzes hospital antibiotic prescribing patterns using AMR’s comprehensive and highly detailed clinical data in conjunction with Decision Resources’ disease area knowledge, primary research and extensive understanding of emerging therapies and forecasts. These reports examine the reasons behind physicians’ product preferences, factors driving hospital antibiotic prescribing patterns and receptivity to emerging antibiotics.

Who should buy these reports and why?

Pharmaceutical companies with products on the market 

• What are the reasons physicians prefer/do not prefer my product for nosocomial pneumonia, skin and structure infections and other hospital-treated infections?
• What factors do physicians believe would increase use of my product?
• Who are my most important customers (prescribers) and in which specialties am I gaining/losing usage?
• How is my product being used compared to competitors?
  What kind of impact will emerging antibiotics have on my product?

Pharmaceutical companies with products in late-stage development 

• What are the main drivers of prescribing in nosocomial pneumonia, skin and structure infections and other hospital-treated infections?
• What do physicians value the most in a new antibiotic?
• What share can my product capture and which antibiotics/combinations do physicians believe my product will replace?
• How are my competitors’ products being used and who prescribes them?